Therapeutic Peptides Expanded 2 intermediate
Imipenem/Relebactam: Oligopeptide Research Reference
Imipenem/Relebactam, a bioactive peptide compound with documented applications in biomedical research, pharmacological studies, and therapeutic development
By Encyclopeptide Editorial | 1 min read
therapeutic-peptides-expanded-2 peptide oligopeptide
Overview
Imipenem/Relebactam is a bioactive peptide with well-characterized properties and therapeutic applications.
Structure
| Property | Value |
|---|---|
| Name | Imipenem/Relebactam |
| Sequence | Combination: imipenem (carbapenem) + cilastatin + relebactam (diazabicyclooctane beta-lactamase inhibitor) |
| Length | Small molecule combination |
| Molecular Weight | 300 Da (imipenem) + 298 Da (relebactam) |
| Category | Anti-Infective / Beta-Lactamase Inhibitor Combination |
Mechanism of Action
Relebactam inhibits Class A and Class C beta-lactamases (including KPC); imipenem kills bacteria via PBP binding. Cilastatin prevents renal metabolism of imipenem
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Test Your Knowledge
Reinforce what you learned about Imipenem/Relebactam: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept